Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

NCT01938248 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

4012

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Stroke

Interventions

DRUG: Apixaban
DRUG: aspirin

Sponsor

Population Health Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]